• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

John Lauerman

    Page 2 of 2

  • People lay on the grass in circles drawn to promote social distancing at Alamo Square in San Francisco, California.Health

    What to know about a potential ‘second wave’ of COVID-19

    By John Lauerman and Bloomberg
  • WASHINGTON, May 12, 2020 — Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a teleconference hearing hosted by a Senate panel on the White House’s response to the coronavirus, in Washington D.C., the United States, May 12, 2020. Anthony Fauci, a top expert on infectious diseases in the United […]Health

    Dr. Fauci’s worst nightmare? We’re living it

    By John Lauerman, Riley Griffin, and others
  • Hydroxychloroquine study shows deaths, heart risks in COVID-19 patientsHealth

    Hydroxychloroquine linked to deaths and heart risks in new COVID-19 study after Trump touted and claimed to be taking the drug

    By John Lauerman and Bloomberg
  • Facade with logo at office of pharmaceutical company AstaZeneca. The U.K. pharm giant will get $1 billion from the United States to scale up production of an experimental Covid-19 vaccine being developed in the labs at University of Oxford.Health

    British pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine

    By John Lauerman and Bloomberg
  • People in March wearing protective masks and suits carry rubbish bins during disinfection work at Huanan Wholesale Seafood Market in Wuhan, Hubei Province of China. WHO scientists on Friday said they are considering a new mission to China to get more information about the virus’s animal origin.Health

    Coronavirus originated in bats, WHO says, but scientists also see link to cats, ferrets and pangolins

    By Janice Kew, John Lauerman, and others
  • Cambridge Biotech Moderna Leads in Race For Coronavirus VaccineInternational

    WHO raises prospect of deliberately infecting healthy volunteers to speed up coronavirus vaccines

    By Corinne Gretler, John Lauerman, and others
  • The Jenner Institute is where the first human trials of a coronavirus vaccine developed by researchers at the University of Oxford is taking place. On Thursday, AstraZeneca Plc announced it would join forces to make the vaccines.Health

    In race to make a coronavirus vaccine, AstraZeneca joins forces with Oxford University

    By Marthe Fourcade, John Lauerman, and others
  • LONDON, ENGLAND - APRIL 07: Media gather outside St Thomas' Hospital on April 07, 2020 in London, England. Prime Minister Boris Johnson was transferred to the intensive care unit at St Thomas' Hospital after his coronavirus symptoms worsened last night. (Photo by Justin Setterfield/Getty Images)International

    What coronavirus hospital data tells us about ICU patients like Boris Johnson

    By John Lauerman, Marthe Fourcade, and others
  • LONDON, UNITED KINGDOM - MARCH 26: In this photo illustration a pack of Hydroxychloroquine Sulfate medication is displayed on March 26, 2020 in London, United Kingdom. The Coronavirus (COVID-19) pandemic has spread to many countries across the world, claiming over 20,000 lives and infecting hundreds of thousands more. U.S. President Donald Trump recently promoted Hydroxychloroquine, a common anti-malaria drug, as a potential treatment for COVID-19 when combined with the antibiotic azithromycin. “HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine,” President Trump tweeted last week. (Photo by John Phillips/Getty Images)Health

    Malaria drug Trump touted as coronavirus treatment has been given FDA emergency authorization

    By John Lauerman and Bloomberg
  • Diabetes medicine pillsHealth

    FDA Is Testing Diabetes Drug Metformin for NDMA, a Carcinogen

    By John Lauerman and Bloomberg
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.